Cross-Regional Strategic In-Licensing


Core Focus

Empowering your growth by identifying and securing strategic assets from across the globe to strengthen your pipeline and market position.

Ideal For

Innovative biotech companies with clinical-stage assets, seeking to partner with leading Chinese pharma companies.

Our Approach

We act as your external R&D and strategy arm. Leveraging our extensive global network and rigorous assessment capabilities, we source, evaluate, and secure high-fit assets through flexible licensing models. We turn market intelligence into a strategic advantage, fueling your sustainable growth.

Key Service Modules

1. Strategic Sourcing & Screening: Global, systematic identification and filtering of assets based on your defined criteria.
2. Scientific & Commercial Due Diligence: In-depth evaluation of clinical, regulatory, and commercial potential.
3. Deal Structuring & Negotiation: Crafting agreements that balance risk and reward to ensure successful integration.
4. Deal Integration Support: Facilitating knowledge transfer and collaboration initiation for a seamless transition.

Our Differentiation

We go beyond finding assets; we find the right assets, ensuring every in-licensing move is a strategic step forward.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us